Reset filter
Keywords
Colorectal Neoplasms ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
    1. 7.1. Anesthesiology
    1. 7.2. Dermatology
    1. 7.3. ENT
    1. 7.4. Geriatrics
    1. 7.5. Gynecology/Obstetrics
    1. 7.6. Internal Medicine
      1. Hematology
      1. Infectious Diseases
      1. Cardiology/Angiology
      1. Pneumology
      1. Gastroenterology
      1. Nephrology
      1. Endocrinology/Metabolic Diseases
      1. Rheumatology
    1. 7.7. Neurology
    1. 7.8. Ophthalmology
    1. 7.9. Palliative Care
    1. 7.10. Pathology/Forensics
    1. 7.11. Pediatrics
    1. 7.12. Psychiatry/Psychosomatics
    1. 7.13. Radiology
    1. 7.14. Surgery
      1. General/Visceral Surgery
      1. Neurosurgery
      1. Plastic Surgery
      1. Thoracic Surgery
      1. Trauma/Orthopedics
      1. Vascular Surgery
    1. 7.15. Urology
    1. 7.16. Dental Medicine/OMS
Selected data models

You must log in to select data models for download or further analysis.

498 Search results.
Relevance Rating New first Old first

Pathology - Colon and Rectum Carcinoma - Anatomic Pathology Form - 2019345v2.31 - Colon and Rectum Carcinoma - Anatomic Pathology Form

- 1/8/15 - 1 form, 4 itemgroups, 65 items, 1 language
Itemgroups: COLORECTAL: CRF HEADER , COLORECTAL PATHOLOGY: FORM ADMINISTRATION, PATHOLOGY: SURGICAL PATHOLOGY - MACROSCOPIC/GROSS DESCRIPTION, PATHOLOGY: SURGICAL PATHOLOGY - MICROSCOPIC DESCRIPTION
Colon and Rectum Carcinoma - Anatomic Pathology Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A97A-3FA4-E034-080020C9C0E0

dbGaP phs001003 Prospective Procurement of Solid Tumor Tissue to Identify Novel Therapeutic Targets - pht010322.v2.p1

- 11/6/23 - 6 forms, 1 itemgroup, 2 items, 1 language
Itemgroup: pht010322
Principal Investigator: Steven A. Rosenberg, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA MeSH: Colonic Neoplasms,Ovarian Neoplasms,Stomach Neoplasms,Cholangiocarcinoma,Pancreatic Neoplasms,Rectal Neoplasms,Esophageal Neoplasms,Colorectal Neoplasms,Endometrial Neoplasms,Paraneoplastic Syndromes, Ocular https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001003 Recent advances and insights into the molecular pathogenesis of cancer have led to the development of novel molecular and biologic targeted therapies for the treatment of advanced cancer patients. A critical challenge in extending these studies involves the identification and validation of new therapeutic targets for future cancer therapies. In this study, we performed whole exome and RNA-Seq analysis metastases to determine the nature and frequency of somatic mutations.

pht010323.v2.p1

1 itemgroup 2 items

pht010324.v2.p1

1 itemgroup 4 items

pht010325.v1.p1

1 itemgroup 2 items

pht010326.v2.p1

1 itemgroup 5 items

Eligibility

1 itemgroup 9 items

Eligibility Liver Metastasis NCT00068068

- 10/8/16 - 1 form, 2 itemgroups, 21 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT00068068

Colon cancer (NSABP C-08 NCT00096278) - REGISTRATION FORM Colon cancer (NCT00096278)

- 9/20/21 - 1 form, 3 itemgroups, 64 items, 1 language
Itemgroups: Header, Patient characteristics, Eligibility Checklist
NSABP PROTOCOL C-08: REGISTRATION FORM Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer NCT00096278 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D7F6865F-B506-428D-E034-0003BA12F5E7

Eligibility Unresectable Liver Metastasis of Colorectal Cancer NCT00869271

- 7/5/17 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00869271

E5202 Colon Cancer On-Study Form NCT00217737

- 7/8/15 - 1 form, 9 itemgroups, 33 items, 1 language
Itemgroups: Header, Patient demographics, Data amendment, Baseline Evaluation, Pathologic Staging, CEA, Disease Description, Biological Markers, Comments
E5202 Colon Cancer On-Study Form NCT00217737 Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EF21AC34-1C36-1B9F-E034-0003BA3F9857

Eligibility Colorectal Cancer NCT02419586

- 12/13/18 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effectiveness of Gum Chewing on Ileus in Chinese Colorectal Patients Underwent Laparoscopic Colorectal Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT02419586

NSABP PROTOCOL C-08: LIVER FUNCTION TEST FORM NCT00096278 - NSABP PROTOCOL C-08: LIVER FUNCTION TEST FORM NCT00096278

- 7/3/15 - 1 form, 2 itemgroups, 25 items, 1 language
Itemgroups: Header, Liver function
NSABP PROTOCOL C-08: LIVER FUNCTION TEST FORM NCT00096278 Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EF512FA7-1C84-1AF2-E034-0003BA3F9857

Eligibility Potentially Resectable Liver Metastasis From CRC NCT00997685

- 8/30/18 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC); ODM derived from: https://clinicaltrials.gov/show/NCT00997685

NCT00096278 NSABP PROTOCOL C-08: LIVER FUNCTION TEST FOLLOW-UP FORM

- 7/3/15 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Header, Liver function
NCT00096278 NSABP PROTOCOL C-08: LIVER FUNCTION TEST FOLLOW-UP FORM Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EF5136E1-073F-1BFA-E034-0003BA3F9857

Registration/Randomization Eligibility Checklist Colon Cancer N0147 NCT00079274

- 9/20/21 - 1 form, 6 itemgroups, 51 items, 1 language
Itemgroups: Header module, Required Characteristics - Randomization (to Arm A or D), Required Characteristics - Registration (to Arm G), Stratification Factors at the Time of Randomization, Descriptive Factors at the Time of Registration/Randomization, Protocol Design
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=70E2C30D-79F3-2C30-E040-BB89AD435E55

Pre-Randomization Colon Cancer Stage III N0147 NCT00079274

- 9/20/21 - 1 form, 12 itemgroups, 70 items, 1 language
Itemgroups: Header module, Visit, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics, KRAS Results Contact, KRAS Results Contact (alternate), Eligibility Check, Contraindications, Pre-Randomization Check, The following will also be recorded:, The following will also be recorded:, Protocol Design
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=70E10B08-8A7D-A35C-E040-BB89AD432A74

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial